Chih-Yu Huang

Title: Innovations of Chih-Yu Huang in Quinic Acid Derivatives

Introduction

Chih-Yu Huang is a notable inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of pharmaceuticals through his innovative work on quinic acid derivatives. His research focuses on the preparation and applications of these compounds, which have important implications for treating various immune disorders.

Latest Patents

Chih-Yu Huang holds a patent for a quinic acid derivative, which is described as a compound that binds to CD28 and blocks the T-cell signal 2 pathway. This mechanism effectively suppresses T-cell activation, making it a potential treatment for autoimmune diseases, allergies, transplant rejection, and other related immune disorders. The preparation process of this quinic acid derivative involves two steps: treating quinic acid with a first reagent in the presence of an acid catalyst to form an intermediate, followed by treatment with a second reagent to produce the final derivative. He has 1 patent to his name.

Career Highlights

Chih-Yu Huang is affiliated with the National Applied Research Laboratories, where he continues to advance his research in the field of pharmaceuticals. His work is characterized by a commitment to developing innovative solutions that address critical health issues.

Collaborations

Chih-Yu Huang has collaborated with esteemed colleagues such as Hueih-Min Chen and Chung-Ming Sun. Their combined expertise contributes to the advancement of research in the pharmaceutical sector.

Conclusion

Chih-Yu Huang's contributions to the field of quinic acid derivatives highlight his innovative spirit and dedication to improving healthcare solutions. His work not only showcases his inventiveness but also has the potential to make a significant impact on the treatment of immune-related disorders.